Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Parkinson's drug
Biotech
Roche's Prothena-partnered Parkinson's prospect fails phase 2b
Days after the failure of UCB's Novartis-partnered program, Roche has shared details of its own alpha-synuclein flop while clinging onto signs of clinical benefit.
Nick Paul Taylor
Dec 19, 2024 4:31am
Gain's Parkinson's drug helps mice retain cognitive function
Jul 2, 2024 6:00am
Gain's clinical Parkinson's drug restores motor function in mice
Feb 6, 2024 8:00am
Open science contest uses AI to ID hits for Parkinson’s
Jan 18, 2024 5:00am
Aptinyx dumps dementia drug, stops PTSD trial after phase 2 flop
Feb 28, 2023 6:15am
Qiagen to develop companion diagnostic for Parkinson's drug
Sep 16, 2022 11:53am
